Companies
/
Lyra Health
Healthtech
Lyra Health is a San Francisco-based mental health benefits company that connects employees at large companies with therapists, coaches, and psychiatric providers through an employer-sponsored platform.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Lyra Health was founded in 2015 by David Ebersman, a former chief financial officer of Facebook, based on the observation that traditional employer-sponsored mental health benefits, most commonly delivered through limited Employee Assistance Programs offering only a handful of free therapy sessions, were poorly suited to addressing employees' actual ongoing mental health needs, motivating Ebersman to build a more comprehensive mental health benefits platform giving employees more meaningful and sustained access to appropriate levels of mental health care. Lyra's platform matches employees with an appropriate mental health provider from its network based on their specific needs, spanning a spectrum from lower-intensity coaching and self-guided digital tools through traditional therapy and, for more severe needs, psychiatric medication management and higher-intensity care programs, aiming to provide the right level of care intensity for each individual employee's specific situation rather than a one-size-fits-all benefit design. The company has emphasized its clinical outcomes measurement and quality assurance processes for its therapist and provider network as a key differentiator, arguing the company emphasizes clinical-outcomes measurement and provider quality-assurance processes as part of its approach to care delivery rather than simply providing access to any available mental health provider regardless of quality or fit. Lyra Health has raised very substantial venture funding from investors including Adams Street Partners and Coatue, reaching a valuation exceeding $5.5 billion at its peak, competing with Spring Health and Modern Health in the employer-sponsored mental health benefits category.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
| Company | Valuation |
|---|---|
Open Neuralink Healthtech |
| $51.4B |
Open Isomorphic Labs Artificial Intelligence | $47.6B |
Open Devoted Health Healthtech | $27.4B |
Open Oura Healthtech | $15.4B |
Open OpenEvidence Artificial Intelligence | $12.8B |
Sign up with Augment to see the latest market activity.
